2016
DOI: 10.1016/j.ihj.2016.02.011
|View full text |Cite
|
Sign up to set email alerts
|

Hemolysis induced by PMIVSD occluder

Abstract: Hemolysis related to occluder, prosthetic valve, and prosthetic ring used for mitral valve annuloplasty are not very unusual. However, hemolysis related to transcathetor closure of post-myocardial infarction ventricular septal defect (PMIVSD) is infrequent. A close follow-up for spontaneous resolution with or without blood transfusion has been reported in a few cases. Occasionally, surgical retrieval is unavoidable or lifelong blood transfusion is required if surgery cannot be done because of higher risk. In t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 12 publications
(13 reference statements)
0
2
0
Order By: Relevance
“…92 Observation and conservative management are oftentimes successful; however, occasionally coil closure of a residual VSD or device removal/surgical repair is warranted. 93,94 Although intravascular hemolysis continues to present quantifiable problems in renal and hepatic dysfunction, as well as problems that are harder to quantify such as systemic inflammatory response, coagulopathy, and vasculopathy, ongoing research has provided some promise. Recently, plasma exchange to treat acute hemolysis after VAD placement was described; however, this offers only a stopgap until the underlying source is addressed.…”
Section: Hematologic Considerationsmentioning
confidence: 99%
See 1 more Smart Citation
“…92 Observation and conservative management are oftentimes successful; however, occasionally coil closure of a residual VSD or device removal/surgical repair is warranted. 93,94 Although intravascular hemolysis continues to present quantifiable problems in renal and hepatic dysfunction, as well as problems that are harder to quantify such as systemic inflammatory response, coagulopathy, and vasculopathy, ongoing research has provided some promise. Recently, plasma exchange to treat acute hemolysis after VAD placement was described; however, this offers only a stopgap until the underlying source is addressed.…”
Section: Hematologic Considerationsmentioning
confidence: 99%
“…92 Observation and conservative management are oftentimes successful; however, occasionally coil closure of a residual VSD or device removal/surgical repair is warranted. 93,94…”
Section: Hematologic Considerationsmentioning
confidence: 99%